Logo image of CS.CA

CAPSTONE COPPER CORP (CS.CA) Stock Fundamental Analysis

TSX:CS - Toronto Stock Exchange - CA14071L1085 - Common Stock - Currency: CAD

8.2  -0.54 (-6.18%)

Fundamental Rating

4

Taking everything into account, CS scores 4 out of 10 in our fundamental rating. CS was compared to 818 industry peers in the Metals & Mining industry. There are concerns on the financial health of CS while its profitability can be described as average. CS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CS had positive earnings in the past year.
CS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CS reported negative net income in multiple years.
CS had a positive operating cash flow in each of the past 5 years.
CS.CA Yearly Net Income VS EBIT VS OCF VS FCFCS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M

1.2 Ratios

With an excellent Return On Assets value of 0.39%, CS belongs to the best of the industry, outperforming 85.27% of the companies in the same industry.
Looking at the Return On Equity, with a value of 0.82%, CS belongs to the top of the industry, outperforming 85.81% of the companies in the same industry.
With an excellent Return On Invested Capital value of 1.54%, CS belongs to the best of the industry, outperforming 88.65% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CS is significantly below the industry average of 11.82%.
Industry RankSector Rank
ROA 0.39%
ROE 0.82%
ROIC 1.54%
ROA(3y)4.56%
ROA(5y)2.67%
ROE(3y)7.65%
ROE(5y)4.49%
ROIC(3y)4.93%
ROIC(5y)3.52%
CS.CA Yearly ROA, ROE, ROICCS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

1.3 Margins

Looking at the Profit Margin, with a value of 1.64%, CS belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
The Operating Margin of CS (8.40%) is better than 89.32% of its industry peers.
CS's Operating Margin has declined in the last couple of years.
The Gross Margin of CS (11.85%) is better than 85.41% of its industry peers.
CS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.4%
PM (TTM) 1.64%
GM 11.85%
OM growth 3Y-32.08%
OM growth 5Y-29.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.63%
GM growth 5Y-19.66%
CS.CA Yearly Profit, Operating, Gross MarginsCS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CS is destroying value.
CS has more shares outstanding than it did 1 year ago.
CS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CS is higher compared to a year ago.
CS.CA Yearly Shares OutstandingCS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
CS.CA Yearly Total Debt VS Total AssetsCS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

CS has an Altman-Z score of 1.12. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CS (1.12) is comparable to the rest of the industry.
CS has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.44, CS is doing worse than 78.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z 1.12
ROIC/WACC0.18
WACC8.48%
CS.CA Yearly LT Debt VS Equity VS FCFCS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.85 indicates that CS may have some problems paying its short term obligations.
The Current ratio of CS (0.85) is worse than 66.89% of its industry peers.
CS has a Quick Ratio of 0.85. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
CS's Quick ratio of 0.58 is on the low side compared to the rest of the industry. CS is outperformed by 70.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.58
CS.CA Yearly Current Assets VS Current LiabilitesCS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 75.00% over the past year.
The Revenue has grown by 11.20% in the past year. This is quite good.
The Revenue has been growing by 26.47% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)11.2%
Revenue growth 3Y43.66%
Revenue growth 5Y26.47%
Sales Q2Q%30.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Based on estimates for the next years, CS will show a very strong growth in Revenue. The Revenue will grow by 24.83% on average per year.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.18%
Revenue Next 2Y30.39%
Revenue Next 3Y25.5%
Revenue Next 5Y24.83%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CS.CA Yearly Revenue VS EstimatesCS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CS.CA Yearly EPS VS EstimatesCS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 82.00, which means the current valuation is very expensive for CS.
86.22% of the companies in the same industry are more expensive than CS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 29.62. CS is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 15.42 indicates a correct valuation of CS.
CS's Price/Forward Earnings ratio is rather cheap when compared to the industry. CS is cheaper than 89.46% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, CS is valued a bit cheaper.
Industry RankSector Rank
PE 82
Fwd PE 15.42
CS.CA Price Earnings VS Forward Price EarningsCS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CS is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.47
CS.CA Per share dataCS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The decent profitability rating of CS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CAPSTONE COPPER CORP

TSX:CS (2/21/2025, 7:00:00 PM)

8.2

-0.54 (-6.18%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)04-30 2025-04-30
Inst Owners30.49%
Inst Owner ChangeN/A
Ins Owners2.66%
Ins Owner ChangeN/A
Market Cap6.25B
Analysts85
Price Target12.83 (56.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.88%
Min EPS beat(2)-36.79%
Max EPS beat(2)-16.97%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.74%
Min Revenue beat(2)-8.94%
Max Revenue beat(2)-4.54%
Revenue beat(4)1
Avg Revenue beat(4)-3.93%
Min Revenue beat(4)-8.94%
Max Revenue beat(4)1.26%
Revenue beat(8)2
Avg Revenue beat(8)-4%
Revenue beat(12)5
Avg Revenue beat(12)3.21%
Revenue beat(16)8
Avg Revenue beat(16)4.36%
PT rev (1m)-5.14%
PT rev (3m)-8.04%
EPS NQ rev (1m)-36.43%
EPS NQ rev (3m)-53.18%
EPS NY rev (1m)-29.78%
EPS NY rev (3m)-43.14%
Revenue NQ rev (1m)-5.19%
Revenue NQ rev (3m)-10.8%
Revenue NY rev (1m)-2.22%
Revenue NY rev (3m)-4.07%
Valuation
Industry RankSector Rank
PE 82
Fwd PE 15.42
P/S 2.92
P/FCF N/A
P/OCF 15.04
P/B 1.47
P/tB 1.47
EV/EBITDA 13.47
EPS(TTM)0.1
EY1.22%
EPS(NY)0.53
Fwd EY6.48%
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)0.55
OCFY6.65%
SpS2.81
BVpS5.6
TBVpS5.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.39%
ROE 0.82%
ROCE 2.23%
ROIC 1.54%
ROICexc 1.57%
ROICexgc 1.57%
OM 8.4%
PM (TTM) 1.64%
GM 11.85%
FCFM N/A
ROA(3y)4.56%
ROA(5y)2.67%
ROE(3y)7.65%
ROE(5y)4.49%
ROIC(3y)4.93%
ROIC(5y)3.52%
ROICexc(3y)5.84%
ROICexc(5y)4.1%
ROICexgc(3y)5.84%
ROICexgc(5y)4.1%
ROCE(3y)7.01%
ROCE(5y)5.02%
ROICexcg growth 3Y-40.07%
ROICexcg growth 5Y-33.83%
ROICexc growth 3Y-40.07%
ROICexc growth 5Y-33.83%
OM growth 3Y-32.08%
OM growth 5Y-29.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.63%
GM growth 5Y-19.66%
F-Score7
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA 3.17
Cap/Depr 156.72%
Cap/Sales 30.11%
Interest Coverage 14.42
Cash Conversion 70.37%
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.58
Altman-Z 1.12
F-Score7
WACC8.48%
ROIC/WACC0.18
Cap/Depr(3y)240.39%
Cap/Depr(5y)191.14%
Cap/Sales(3y)35.27%
Cap/Sales(5y)30.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.2%
Revenue growth 3Y43.66%
Revenue growth 5Y26.47%
Sales Q2Q%30.16%
Revenue Next Year25.18%
Revenue Next 2Y30.39%
Revenue Next 3Y25.5%
Revenue Next 5Y24.83%
EBIT growth 1Y93.17%
EBIT growth 3Y-2.43%
EBIT growth 5Y-10.31%
EBIT Next Year1296.55%
EBIT Next 3Y233.61%
EBIT Next 5Y127.47%
FCF growth 1Y43.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.86%
OCF growth 3Y-7.42%
OCF growth 5Y-2.28%